185 related articles for article (PubMed ID: 23758483)
1. Normal adiponectin levels in kidney transplant patients with hypertension.
Leibowitz A; Peleg E; Ben-David A; Sharabi Y; Kamari Y; Holzman E; Grossman E
Clin Transplant; 2013; 27(4):562-6. PubMed ID: 23758483
[TBL] [Abstract][Full Text] [Related]
2. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
[TBL] [Abstract][Full Text] [Related]
3. Evidence of enhanced systemic inflammation in stable kidney transplant recipients with low Framingham risk scores.
Mansell H; Rosaasen N; Dean J; Shoker A
Clin Transplant; 2013; 27(4):E391-9. PubMed ID: 23782452
[TBL] [Abstract][Full Text] [Related]
4. Serum adiponectin levels and ambulatory blood pressure monitoring in pediatric renal transplant recipients.
Sethna CB; Leonard MB; Gallagher PR; Meyers KE
Transplantation; 2009 Oct; 88(8):1030-7. PubMed ID: 19855250
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin and cardiovascular outcomes among hemodialysis patients.
Abdallah E; Waked E; Nabil M; El-Bendary O
Kidney Blood Press Res; 2012; 35(4):247-53. PubMed ID: 22286012
[TBL] [Abstract][Full Text] [Related]
6. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.
Svensson M; Dahle DO; Mjøen G; Weihrauch G; Scharnagl H; Dobnig H; März W; Jardine A; Fellström B; Holdaas H
Nephrol Dial Transplant; 2012 Jun; 27(6):2571-5. PubMed ID: 22172725
[TBL] [Abstract][Full Text] [Related]
7. Low pre-transplant adiponectin multimers are associated with adverse allograft outcomes in kidney transplant recipients a 3-year prospective study.
Roos M; Baumann M; Liu D; Heinemann FM; Lindemann M; Horn PA; Türk T; Lutz J; Heemann U; Witzke O; von Eynatten M
Regul Pept; 2012 Oct; 178(1-3):11-5. PubMed ID: 22750635
[TBL] [Abstract][Full Text] [Related]
8. Plasma adiponectin levels for prediction of cardiovascular risk among hemodialysis patients.
El-Shafey EM; Shalan M
Ther Apher Dial; 2014 Apr; 18(2):185-92. PubMed ID: 24720410
[TBL] [Abstract][Full Text] [Related]
9. High-sensitivity troponin T levels in kidney transplant recipients.
Arroyo D; Quiroga B; Panizo N; Rodríguez-Ferrero M; Macías N; Reque J; Anaya F; Luño J
Transplant Proc; 2012 Nov; 44(9):2545-7. PubMed ID: 23146449
[TBL] [Abstract][Full Text] [Related]
10. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study.
Becker B; Kronenberg F; Kielstein JT; Haller H; Morath C; Ritz E; Fliser D;
J Am Soc Nephrol; 2005 Apr; 16(4):1091-8. PubMed ID: 15743998
[TBL] [Abstract][Full Text] [Related]
11. Ambulatory blood pressure monitoring in kidney transplant patients: RETENAL study.
Fernandez Fresnedo G; Franco Esteve A; Gómez Huertas E; Cabello Chaves V; Díz Gómez JM; Osorio Moratalla JM; Gallego Samper R; Gallego Valcárcel E; Campistol Plana JM; Marín Iranzo R; Arias Rodríguez M;
Transplant Proc; 2012 Nov; 44(9):2601-2. PubMed ID: 23146468
[TBL] [Abstract][Full Text] [Related]
12. Serum adiponectin levels in renal transplant recipients with and without metabolic syndrome.
Shu KH; Tsai IC; Ho HC; Wu MJ; Chen CH; Cheng CH; Yu TM; Chuang YW; Huang ST
Transplant Proc; 2012 Apr; 44(3):676-9. PubMed ID: 22483466
[TBL] [Abstract][Full Text] [Related]
13. Plasma adiponectin concentrations in patients with chronic renal failure: relationship with metabolic risk factors and ischemic heart disease.
Tentolouris N; Doulgerakis D; Moyssakis I; Kyriaki D; Makrilakis K; Kosmadakis G; Stamatiadis D; Katsilambros N; Stathakis C
Horm Metab Res; 2004 Oct; 36(10):721-7. PubMed ID: 15523599
[TBL] [Abstract][Full Text] [Related]
14. The effect of renal transplantation on adiponectin and its isoforms and receptors.
Shen YY; Charlesworth JA; Kelly JJ; Peake PW
Metabolism; 2007 Sep; 56(9):1201-8. PubMed ID: 17697862
[TBL] [Abstract][Full Text] [Related]
15. The impact of living donor kidney transplantation on markers of cardiovascular risk in chronic kidney disease patients.
Bignelli AT; Barberato SH; Aveles P; Abensur H; Pecoits-Filho R
Blood Purif; 2007; 25(3):233-41. PubMed ID: 17377377
[TBL] [Abstract][Full Text] [Related]
16. Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients.
Dahle DO; Jenssen T; Holdaas H; Leivestad T; Vårdal M; Mjøen G; Reisaeter AV; Toft I; Hartmann A
Clin Transplant; 2014 Jan; 28(1):134-40. PubMed ID: 24372653
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.
Guebre-Egziabher F; Bernhard J; Funahashi T; Hadj-Aissa A; Fouque D
Nephrol Dial Transplant; 2005 Jan; 20(1):129-34. PubMed ID: 15585515
[TBL] [Abstract][Full Text] [Related]
18. Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status.
Norata GD; Baragetti I; Raselli S; Stucchi A; Garlaschelli K; Vettoretti S; Piloni G; Buccianti G; Catapano AL
Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):56-63. PubMed ID: 19359150
[TBL] [Abstract][Full Text] [Related]
19. Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients.
Filippidis G; Liakopoulos V; Mertens PR; Kiropoulos T; Stakias N; Verikouki C; Patsidis E; Koukoulis G; Stefanidis I
Blood Purif; 2005; 23(6):421-8. PubMed ID: 16141714
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study.
Kaisar MO; Armstrong K; Hawley C; Campbell S; Mudge D; Johnson DW; Prins JB; Isbel NM
BMC Nephrol; 2009 Oct; 10():29. PubMed ID: 19821969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
